TRCT
OMGA

Tower Research Capital (TRC)’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Tower Research Capital (TRC)’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-292
Closed -$218 – 6005
2024
Q4 		$218 Sell
292
-4,278
-94% -$4.26K ﹤0.01% 5373
2024
Q3 		$5.58K Sell
4,570
-7,449
-62% -$11.9K ﹤0.01% 4249
2024
Q2 		$24.9K Buy
12,019
+6,884
+134% +$16.2K ﹤0.01% 3626
2024
Q1 		$18.7K Buy
5,135
+1,086
+27% +$4.16K ﹤0.01% 3057
2023
Q4 		$12.2K Sell
4,049
-859
-18% -$1.74K ﹤0.01% 4069
2023
Q3 		$10.6K Buy
4,908
+2,834
+137% +$11.3K ﹤0.01% 4096
2023
Q2 		$11.6K Sell
2,074
-10,089
-83% -$78.9K ﹤0.01% 3956
2023
Q1 		$74K Buy
12,163
+8,211
+208% +$57.2K ﹤0.01% 2158
2022
Q4 		$23K Sell
3,952
-5,011
-56% -$28.1K ﹤0.01% 3017
2022
Q3 		$49K Buy
8,963
+3,753
+72% +$19K ﹤0.01% 3179
2022
Q2 		$19K Buy
5,210
+3,537
+211% +$13.2K ﹤0.01% 3868
2022
Q1 		$10K Sell
1,673
-2,941
-64% -$30K ﹤0.01% 4370
2021
Q4 		$52K Buy
4,614
+4,234
+1,114% +$80.5K ﹤0.01% 2736
2021
Q3 		$7K Buy
+380
New +$7.29K ﹤0.01% 4688

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Tower Research Capital (TRC)'s OMGA Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 292 shares — an estimated $218 sold.

Tower Research Capital (TRC) first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $74K in Q1 2023. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 292 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $218.
  • Tower Research Capital (TRC) first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Tower Research Capital (TRC)'s Omega Therapeutics, Inc. Common Stock position peaked at $74K in Q1 2023.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.